A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis

Recruiting

Phase 1

LY4213663A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis

Sponsor:

Eli Lilly and Company

Code:

NCT07258849

Conditions

Rheumatoid Arthritis (RA)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

LY4213663

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-08. This information was provided to ClinicalTrials.gov by Eli Lilly and Company on 2026-06-23.